PNC Financial Services Group’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-252
Closed -$421 5250
2025
Q4
$421 Sell
252
-145
-37% -$251 ﹤0.01% 4878
2025
Q3
$671 Sell
397
-4
-1% -$5 ﹤0.01% 4754
2025
Q2
$364 Buy
401
+355
+772% +$211 ﹤0.01% 4724
2025
Q1
$21 Buy
46
+38
+475% +$22 ﹤0.01% 4864
2024
Q4
$4 Buy
+8
New +$6 ﹤0.01% 4775
2024
Q1
Sell
-180
Closed -$196 4764
2023
Q4
$196 Buy
+180
New +$197 ﹤0.01% 4491
2020
Q3
Sell
-300
Closed 3982
2020
Q2
$0 Hold
300
﹤0.01% 3986
2020
Q1
$0 Hold
300
﹤0.01% 3980
2019
Q4
$0 Hold
300
﹤0.01% 4049
2019
Q3
$0 Sell
300
-10
-3% -$10 ﹤0.01% 4059
2019
Q2
$0 Buy
310
+10
+3% +$12 ﹤0.01% 4081
2019
Q1
$0 Hold
300
﹤0.01% 4084
2018
Q4
$0 Sell
300
-43
-13% -$66 ﹤0.01% 4112
2018
Q3
$0 Hold
343
﹤0.01% 4186
2018
Q2
$0 Hold
343
﹤0.01% 4212
2018
Q1
$0 Hold
343
﹤0.01% 4236
2017
Q4
$0 Hold
343
﹤0.01% 4192
2017
Q3
$0 Sell
343
-91,440
-100% -$227K ﹤0.01% 4186
2017
Q2
$252K Hold
91,783
﹤0.01% 2009
2017
Q1
$278K Hold
91,783
﹤0.01% 1947
2016
Q4
$290K Hold
91,783
﹤0.01% 1908
2016
Q3
$314K Hold
91,783
﹤0.01% 1831
2016
Q2
$210K Hold
91,783
﹤0.01% 2048
2016
Q1
$230K Sell
91,783
-7,710
-8% -$17.2K ﹤0.01% 2018
2015
Q4
$330K Buy
99,493
+12,390
+14% +$37K ﹤0.01% 1762
2015
Q3
$210K Buy
87,103
+372
+0.4% +$963 ﹤0.01% 2084
2015
Q2
$254K Hold
86,731
﹤0.01% 2063
2015
Q1
$348K Buy
86,731
+24,780
+40% +$85.7K ﹤0.01% 1877
2014
Q4
$186K Hold
61,951
﹤0.01% 2120
2014
Q3
$158K Buy
+61,951
New +$149K ﹤0.01% 2133

Other funds holding LCTX